ChiroBlock

ChiroBlock is a specialized German contract research organization (CRO) focused on high-end chemical synthesis and R&D services for the life sciences industry. Established in 1999, the company excels in the design and production of complex organic molecules, particularly chiral compounds and sophisticated small molecule building blocks. ChiroBlock operates as a Contract Research and Development Organization (CRDO), providing customized solutions that range from initial route scouting to the synthesis of reference standards and advanced intermediates. Their expertise supports drug discovery and development phases by overcoming challenging synthetic hurdles for pharmaceutical and biotech clients worldwide. The company is recognized for its 'Synthesis-as-a-Service' model, emphasizing transparent project management and intellectual property security.